Topics

Companies Related to "Dietary vulnerability found cancer cells with mutated spliceosomes" [Most Relevant Company Matches] - Page: 16 RSS

22:01 EST 22nd January 2020 | BioPortfolio

Here are the most relevant search results for "Dietary vulnerability found cancer cells with mutated spliceosomes" found in our extensive corporate database of over 50,000 company records.

Showing "Dietary vulnerability found cancer cells with mutated spliceosomes" Companies 376–400 of 4,000+

Probably Relevant

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at the Barbara Ann Karmanos Cancer Institute to develop a diagnostic tool for the early detection of pancreatic cancer.


California Cancer Specialists Medical Group

Based in Monrovia, Calif., California Cancer Specialists Medical Group is an academic physician practice that provides a comprehensive range of inpatient and outpatient services primarily related to the treatment and prevention of various types of cancer. Comprised of more than 180 nationally recognized physicians experts, California Cancer Specialists physicians are world renowned for innovations...

Xenova

Xenova Group Limited, a fully-owned subsidiary of Celtic Pharma Development plc, is a UK-based biopharmaceutical company focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. The Company has a broad pipeline of drug candidates in clinical development including a novel programme for the treatment of high-grade glioma, TransMIDTM. Details of...


Virginia Cancer Specialists

For more than 30 years, Virginia Cancer Specialists (VCS) has contributed to the campaign against cancer and diseases of the blood. VCS has nine locations throughout Northern Virginia staffed by highly-skilled physicians, each promising exceptional care. This care consists of advancements in early detection, treatment, and clinical trials. Offering emotional as well as physical support, VCS is hom...

Q-Sense AB

Sense AB develops and markets research instruments based on the patented QCM-D (Quartz Crystal Microbalance with Dissipation Monitoring) technique. Since 1999 Q-Sense is the leading supplier of quartz crystal resonantor based instruments for molecular binding events taking place on various surfaces. Q-Sense instruments are found in 20+ countries all over the world. The QCM-D technique gives new op...

WIN Consortium

The WIN Consortium (www.winconsortium.org) is a joint initiative of Institut Gustave Roussy (France) and University of Texas - MD Anderson Cancer Center (USA) which brings together 17 cancer centers around the world, the National Breast Cancer Foundation, Sage Bionetworks and three technology partners: Agilent Technologies, GE Healthcare and Life Technolog...

CDISC and The Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double pancreatic can...

OnKure

OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenv...

Trustwave

Trustwave helps businesses fight cybercrime, protect data and reduce security risk. With cloud and managed security services, integrated technologies and a team of security experts, ethical hackers and researchers, Trustwave enables businesses to transform the way they manage their information security and compliance programs. More than three million busin...

Cyto Pulse Sciences, Inc

Cyto Pulse was founded in December 1995 and is incorporated as a regular corporation in Maryland. The company is composed of a multidisciplinary staff of engineers and scientists. Cyto Pulse develops electric field based devices for use in vaccine delivery, vaccine production, personal vaccine production, gene therapy, and hybridoma production. In recent years, there have been great advances in im...

CTC, Inc. Public Safety Technology Center

CTC's PSTC, headquartered in Westborough, MA, is a non-profit [501(c) (3)] company with expertise in: Science and Technology Technology Transfer State and Local Public Safety Practices & Technology Applications Community and University Vulnerability Assessments Emergency Management, Planning, Training and Exercises Business Development Technology Commercialization Public Safety Technology Center (...

MAFGROUP

B.V.MAGNESIET-EN AMARILFABRIEKEN "MAF" (Magnesite and Emery Works B.V.) at Vlaardingen has been found in 1927 as a logic procedure after the merging of Messrs.Rozenboom / Vlaardingen with the Magnesite Works N.V. The later has been found in 1902 by Mr. Frans van der Ven sr. The main activity was trading of Magnesite and Emery. In 1975 MAF Magnesite B.V. was found as a spin off of the B.V.Magnesiet...

Cancer Research Technology Limited (CRT)

Cancer Research Technology Limited (CRT) is the leading oncology focused technology transfer and development company which aims to maximise cancer patient benefit from publicly funded research. CRT works closely with leading international cancer scientists, institutes and funding bodies to protect and develop intellectual property arising from their research and to establish links with commercial ...

Silicon Biosystems, Inc.

Silicon Biosystems, Inc. was formed in October of 2010 as a wholly owned subsidiary of Silicon Biosystems, S.p.A. based in Bologna, Italy. The Company manufactures and sells the DEPArray™ platform which is based on the principle of dielectrophoresis to isolate and manipulate cells in suspension with a microelectronic array. The approach, patented by S...

Novocell, Inc

Novocell’s goal is to develop a renewable source of specialized cells that can be used to treat chronic cellular diseases. To achieve this goal, Novocell is uniquely positioned to exploit human stem cell engineered product opportunities using its proprietary cell encapsulation technology. Combined with Novocell's expertise in cell transplantation, these technologies will allow large numbers of p...

BIOFIL LABORATORY

The particularity of Cytophylactie concept is to give to the beauticians the power of decision to meet ALL of the skin's vital needs. For BIOFIL, only the beautician is the ability's person to provide to the skin a healthy and balanced life in order to allow it to progress harmoniously in time..The cytophylactie lies in one simple observation:Normal functioning skin cells engender a healthy skin ...

MacroGenics, Inc.

MacroGenics is a private, venture-backed biotechnology company that focuses on the discovery, development and delivery to patients of novel biologics for autoimmune disorders, cancer and infectious diseases. Since its founding in 2000, the company has built a fully-integrated set of capabilities in monoclonal antibody product development. The company's product development efforts leverage three ...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The company is targeting major central nervous system diseases includi...

OnKure, Inc.

OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenv...

BioLife Solutions

BioLife Solutions (BLFS.OB) is the leader in providing innovative technologies for the preservation of cells and tissues. Our researchers continually analyze the stress pathways activated in cells subjected to preservation and use this information to formulate enhanced preservation solutions that address specific points on the apoptotic cascade. Our science has led us to create a portfolio of so...

Alliance for Childhood Cancer

The Alliance for Childhood Cancer advocates to advance research and policies to improve the diagnosis, treatment, care, and survivorship of children and adolescents with cancer, as well as enhance public awareness. www.allianceforchildhoodcancer.org

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for t...

EntreMed Incorporated

EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is focused on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. EntreMed’s goal is to develop and commercialize therapeutics based on the Company...

Deplin

Deplin® is a medical food available by prescription for the clinical dietary management of the metabolic imbalances associated with depression. It should be used only under medical supervision.7

Boston Biomedical, Inc.

Boston Biomedical, Inc. (Founder, Chairman, CEO and CMO: Chiang J. Li, M.D. FACP) was founded in November, 2006 and is a privately-held biotechnology company focused on the research and development of novel cancer therapeutics. Boston Biomedical has developed a world-leading product pipeline targeting cancer stem cells. Boston Biomedical’s innovation ...


More From BioPortfolio on "Dietary vulnerability found cancer cells with mutated spliceosomes"

Quick Search

Corporate Database Quicklinks